GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Devices & Instruments » OraSure Technologies Inc (FRA:EP3) » Definitions » EBITDA Margin %

OraSure Technologies (FRA:EP3) EBITDA Margin % : -1.89% (As of Mar. 2024)


View and export this data going back to . Start your Free Trial

What is OraSure Technologies EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. OraSure Technologies's EBITDA for the three months ended in Mar. 2024 was €-0.9 Mil. OraSure Technologies's Revenue for the three months ended in Mar. 2024 was €49.8 Mil. Therefore, OraSure Technologies's EBITDA margin for the quarter that ended in Mar. 2024 was -1.89%.


OraSure Technologies EBITDA Margin % Historical Data

The historical data trend for OraSure Technologies's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

OraSure Technologies EBITDA Margin % Chart

OraSure Technologies Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 10.04 2.00 0.36 2.66 15.87

OraSure Technologies Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 18.78 4.76 22.87 14.22 -1.89

Competitive Comparison of OraSure Technologies's EBITDA Margin %

For the Medical Instruments & Supplies subindustry, OraSure Technologies's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


OraSure Technologies's EBITDA Margin % Distribution in the Medical Devices & Instruments Industry

For the Medical Devices & Instruments industry and Healthcare sector, OraSure Technologies's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where OraSure Technologies's EBITDA Margin % falls into.



OraSure Technologies EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

OraSure Technologies's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=59.012/371.818
=15.87 %

OraSure Technologies's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=-0.942/49.801
=-1.89 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


OraSure Technologies  (FRA:EP3) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


OraSure Technologies EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of OraSure Technologies's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


OraSure Technologies (FRA:EP3) Business Description

Traded in Other Exchanges
Address
220 East First Street, Bethlehem, PA, USA, 18015
OraSure Technologies is a medical devices company that develops, manufactures, and distributes oral fluid diagnostic and collection devices. Its reportable segments are diagnostics and molecular solutions. The diagnostics segment produces rapid oral diagnostic tests and specimen collection devices for infectious diseases such as HIV and HCV. The molecular solutions segment specializes in kits used to collect, stabilize, and transport genetic material samples for molecular testing of both hereditary diseases and infectious diseases, such as COVID-19. The company gets most of its sales from the molecular solutions business, derived mainly from customers in the United States.

OraSure Technologies (FRA:EP3) Headlines

No Headlines